Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk R Schultz

Showing results (11-20 of 217) with videos related to

Pageof 22
Sort By:
Experimental Hematology|November 15, 2018
The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantationStephen Couban, Peggy C Wong, Kirk R Schultz
Hematology. American Society of Hematology. Education Program|December 9, 2023
Planning GvHD preemptive therapy: risk factors, biomarkers, and prognostic scoresJacob Rozmus, John E Levine, Kirk R Schultz
Pediatric Hematology and Oncology|June 23, 2021
Has Eltrombopag eliminated the need to use allogeneic HSCT in first line treatment of pediatric aplastic anemia?Chia Huan Ng, Fraser Jang-Milligan, Kirk R Schultz
Bone Marrow Transplantation|April 30, 2021
Successful rescue transplant for children with primary graft failure using early intervention with a single day preparative regimen and related haploidentical donorDivya Subburaj, Amanda M Li, Jacob Rozmus, et al.
Pediatric Clinics of North America|December 2, 2014
Hematopoietic cell transplantation and cellular therapeutics in the treatment of childhood malignanciesKanwaldeep Mallhi, Lawrence G Lum, Kirk R Schultz, et al.
Blood|October 30, 2015
Pediatric chronic myeloid leukemia is a unique disease that requires a different approachNobuko Hijiya, Kirk R Schultz, Markus Metzler, et al.
Pediatric Hematology and Oncology|November 7, 2023
The Onset of Puberty Presents Unique Management Issues in Penile Chronic Graft-versus-Host Disease Requiring Circumcision in Male Pediatric PatientsChia Huan Ng, Juliana P Roden, Jefferson Terry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 17, 2009
Controversies of and unique issues in hematopoietic cell transplantation for infant leukemiaStephen P Hunger, K Mignon Loh, K Scott Baker, et al.
Transplantation and Cellular Therapy|February 9, 2022
Multiple Breath Washout Testing to Identify Pulmonary Chronic Graft Versus Host Disease in Children After Hematopoietic Stem Cell TransplantationJonathan H Rayment, Rodrigo A Sandoval, Juliana P Roden, et al.
European Journal of Immunology|April 14, 2015
Heterodimer-specific TLR2 stimulation results in divergent functional outcomes in B-cell precursor acute lymphoblastic leukemiaNina Rolf, Amina Kariminia, Sabine Ivison, et al.
Pageof 22

Showing results (11-20 of 217) with videos related to

Sort By:
Pageof 22
Experimental Hematology|November 15, 2018
The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantationStephen Couban, Peggy C Wong, Kirk R Schultz
Hematology. American Society of Hematology. Education Program|December 9, 2023
Planning GvHD preemptive therapy: risk factors, biomarkers, and prognostic scoresJacob Rozmus, John E Levine, Kirk R Schultz
Pediatric Hematology and Oncology|June 23, 2021
Has Eltrombopag eliminated the need to use allogeneic HSCT in first line treatment of pediatric aplastic anemia?Chia Huan Ng, Fraser Jang-Milligan, Kirk R Schultz
Bone Marrow Transplantation|April 30, 2021
Successful rescue transplant for children with primary graft failure using early intervention with a single day preparative regimen and related haploidentical donorDivya Subburaj, Amanda M Li, Jacob Rozmus, et al.
Pediatric Clinics of North America|December 2, 2014
Hematopoietic cell transplantation and cellular therapeutics in the treatment of childhood malignanciesKanwaldeep Mallhi, Lawrence G Lum, Kirk R Schultz, et al.
Blood|October 30, 2015
Pediatric chronic myeloid leukemia is a unique disease that requires a different approachNobuko Hijiya, Kirk R Schultz, Markus Metzler, et al.
Pediatric Hematology and Oncology|November 7, 2023
The Onset of Puberty Presents Unique Management Issues in Penile Chronic Graft-versus-Host Disease Requiring Circumcision in Male Pediatric PatientsChia Huan Ng, Juliana P Roden, Jefferson Terry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 17, 2009
Controversies of and unique issues in hematopoietic cell transplantation for infant leukemiaStephen P Hunger, K Mignon Loh, K Scott Baker, et al.
Transplantation and Cellular Therapy|February 9, 2022
Multiple Breath Washout Testing to Identify Pulmonary Chronic Graft Versus Host Disease in Children After Hematopoietic Stem Cell TransplantationJonathan H Rayment, Rodrigo A Sandoval, Juliana P Roden, et al.
European Journal of Immunology|April 14, 2015
Heterodimer-specific TLR2 stimulation results in divergent functional outcomes in B-cell precursor acute lymphoblastic leukemiaNina Rolf, Amina Kariminia, Sabine Ivison, et al.
Pageof 22